Allogeneic umbilical cord blood cells
Allogeneic umbilical cord blood cells has been studied in 1 paper since 2021: none in people yet. No study of it in people or animals has been published yet. The newest paper, Nov 15, 2021: “Efficacy of Cord Blood Cell Therapy for Hutchinson-Gilford Progeria Syndrome-A Case Report”.
1 paper studies it4 findingsUpdated
See all 1 papers on allogeneic umbilical cord blood cells
At a glance
The findings reach people, from one lab or study. 1 lab in 1 country.
“The patient exhibited an increase in growth rate for both height and weight.”
None of its findings points the other way.
- 1 lab in 1 country
- Funder: Korea Health Industry Development Institute
What did studies of allogeneic umbilical cord blood cells find?
4Studies of allogeneic umbilical cord blood cells measured 4 outcomes, among them inflammation, joint range of motion and atherosclerosis.
Inflammation
downin humans1
1 study
Inflammation
downin humans1
Allogeneic umbilical cord blood cells inhibit inflammation in humans (HGPS).
“A molecular assay revealed downregulation of proinflammatory and atherosclerosis, representing cytokine expressions following the administration of CB cells.”
Human trialHGPSallogeneic cord blood cells from unrelated donorsthree intravenous infusions at four-month intervalsmales
Efficacy of Cord Blood Cell Therapy for Hutchinson-Gilford Progeria Syndrome-A Case Report
International journal of molecular sciences
Joint range of motion
upin humans1
1 study
Joint range of motion
upin humans1
Allogeneic umbilical cord blood cells improve joint range of motion in humans (HGPS).
“Further, an increase in flexibility occurred in some joints of the upper extremities.”
Human trialHGPSallogeneic cord blood cells from unrelated donorsthree intravenous infusions at four-month intervalsone yearmales
Efficacy of Cord Blood Cell Therapy for Hutchinson-Gilford Progeria Syndrome-A Case Report
International journal of molecular sciences
Atherosclerosis
downin humans1
1 study
Atherosclerosis
downin humans1
Allogeneic umbilical cord blood cells decrease atherosclerosis in humans (HGPS).
“One year after therapy initiation, evident amelioration in pulse wave velocity, bilateral maximal intima-media thickness, and dyslipidemic status were observed”
Human trialHGPSallogeneic cord blood cells from unrelated donorsthree intravenous infusions at four-month intervalsone yearmales
Efficacy of Cord Blood Cell Therapy for Hutchinson-Gilford Progeria Syndrome-A Case Report
International journal of molecular sciences
Growth rate
upin humans1
1 study
Growth rate
upin humans1
Allogeneic umbilical cord blood cells increase growth rate in humans (HGPS).
“The patient exhibited an increase in growth rate for both height and weight.”
Human trialHGPSallogeneic cord blood cells from unrelated donorsthree intravenous infusions at four-month intervalsmales
Efficacy of Cord Blood Cell Therapy for Hutchinson-Gilford Progeria Syndrome-A Case Report
International journal of molecular sciences